natgillin/translations-raw huggingface dataset:
Gram negative bacteria of enterobacteria selected from E. coli, Klebsiella, Serratia, Enterobacter, Citrobacter, Morganella, Providencia or Proteus; 
– Gram-negativnim bakterijama koje se bira između Gram-negativnih bakterija iz skupine enterobakterija primjerice E. coli, Klebsiella, Serratia, Enterobacter, Citrobacter, Morganella, Providencia ili Proteus;
Use of an anti-VEGF antagonist antibody in the preparation of a medicament for treating a disease having excessive angiogenesis in a subject by administering an anti-VEGF antagonist antibody and an anti-alpha5beta1 antagonist antibody, wherein the anti-VEGF antagonist antibody and the anti-alpha5betal antagonist antibody are administered in concurrent treatment cycles. 
Uporaba protutijela antagonista anti-VEGEF, naznačena time, da je za proizvodnju lijeka za liječenje bolesti koja ima prekomjernu angiogenezu kod pojedinca, pomoću davanja protutijela antagonista anti-VEGF i protutijela HR P20150884 T1 antagonista anti-alfaSbetal, pri čemu se protutijelo antagonista anti- VEGF i protutijelo antagonista anti-alfa5beta1 primjenjuju u sukladnim ciklusima liječenja.
The locking means is preferably arranged to prevent movement of an aforesaid reciprocal connection means relative to an aforesaid headwear connection means being the relative movement via which the reciprocal connection means is detachably attachable to the headwear connection means. 
Slušalice prema zahtjevu 29, naznačene time, da je zaporno sredstvo namješteno za sprečavanje pomaka navedenog recipročnog spojnog uređaja u odnosu na navedeni naglavni spojni uređaj, što je relativni pomak preko kojega se recipročni spojmi uređaj odvojivo priključuje na naglavni spojni uređaj.
forming an image by providing an ink layer of color image elements onto the substrate (30) in an image area (Ai) via the image applicator that is connected to the print controller, applying a protective layer (4) over the substrate (30) in a liquid or softened state, 
dobivanja slike dodavanjem sloja tinte elemenata slike u boji na podlogu (30) u području za sliku (Ai) putem aplikatora slike spojenog s upravljačem tiskanja, - > dodavanja zaštitnog sloja (4) preko podloge (30) u tekućem ili omekšanom stanju, -
According to yet another aspect of the invention, the disclosed compounds and compositions are useful for the amelioration of symptoms associated with, the treatment of, and preventing and/or inhibiting the progression of, the following conditions and diseases: metabolic syndrome, obesity, disorders of energy homeostasis, diabetes, lipid disorders, cardiovascular disorders, artherosclerosis, hyperglycemia, elevated blood glucose level, and insulin resistance. 
Spoj za uporabu kako je zatraženo u zahtjevu 19, naznačen time da bolest, poremećaj ili stanje je odabran iz skupine koja se sastoji od metaboličkog sindroma, pretilosti, poremećaja homeostatske energije, dijabetesa, lipidnih poremećaja, kardiovaskularnih poremećaja, ateroskleroze, hiperglikemije, povišene razine glukoze u krvi, te inzulinske rezistencije.
reacting a compound of the formula IV with an oxalic acid diester of formula V wherein R14 is -(C1-C6)-alkyl, to give a compound of formula VI 
reakciji spoja formule IV [image], s diesterom oksalne kiseline formule V [image], gdje je R14 -(C1-C6)-alkil, kako bi se dobilo spoj formule VI [image],
The method of E 25, wherein the IL-23 antagonist is a humanized monoclonal antibody or a fully human monoclonal antibody. 
IL-17 antagonist za uporabu u skladu sa zahtjevom 25, naznačen time, da IL-23 antagonist je humanizirano monoklonsko antitijelo ili potpuno ljudsko monoklonsko antitijelo, 27.
wherein the at least one organic solvent is present in an amount of at least 50 wt%, based on the weight of the liquid phase of the suspension; and wherein step (b) comprises grinding of the talc suspension, preferably wherein the talc suspension is ground in a ball mill and/or wherein step (b) comprises treatment of the talc suspension in a homogeniser, preferably said homogeniser is a high pressure homogeniser. 
pri čemu je barem jedno organsko otapalo prisutno u količini od barem 50 mas.%, u odnosu na masu tekuće faze suspenzije; i pri čemu korak (b) obuhvaća mljevenje suspenzije talka, poželjno pri čemu se suspenzija talka melje u kugličnom mlinu i/ili pri čemu korak (b) obuhvaća obradu suspenzije talka u homogenizatoru, poželjno navedeni homogenizator je visokotlačni homogenizator.
providing a solution comprising a Lewis acid and water; and adding the Lewis acid solution to the solution of the boron "ate" complex of formula (II) from step (a); 
(1) osiguranje otopine koja sadrži Lewis-ovu kiselinu i vodu; i (ii) dodavanja otopine Lewis-ove kiseline u otopinu kompleksa borata formule (77) iz koraka (a); pri čemu jo otopljivost vodo u eterskom otapalu koje ima nisku mješavost sa vodom manja od 5% tež./tež.
The New Methylene Blue is present in amounts sufficient to result in concentrations of about 735 uM under staining conditions. 
Novo metilensko modrilo je prisutno u dovoljnoj količini da se dobiju koncentracije od oko 735 uM u uvjetima bojenja; i
A process for preparing a compound of formula ((S,S)-SDG-1) or a compound of formula (R,R)-SDG-2 the process comprising: 
PATENTNI ZAHTJEVI 1. > Postupak za pripremu spoja formule (($,S)-SDG-1) ili spoja formule (R,R)-SDG-2 pe
The compound of claim 1 wherein R4 is phenyl substituted at the 4-position with hydroxy, C1-3alkylaminocarbonyl, or aminocarbonyl, and substituted at the 2- and 6- positions with methyl substituents. 
Spoj prema zahtjevu 1 maznačen time da R' je fenil supstituiran na 4-poziciji sa hidroksi, C,salkilaminokarbonilom ili aminokarbonilom i supstituiran na 2- poziciji i 6-poziciji sa metil supstituentima.
Method according to claim 4 or 5, the pre-processing comprising refining the visible lignocellulosic biomass fibres for facilitating interaction between the fibre pulp and the visible lignocellulosic biomass fibres in the pulp mix. 
Metoda u skladu s patentnim zahtjevom 2 ili 3, predobrada obuhvaća pročišćavanje (8) vidljivih vlakana lignocelulozne biomase za postizanje međudjelovanja između pulpe vlakana i vidljivih vlakana lignocelulozne biomase u smjesi pulpe.
A method of treating a patient in need thereof comprising the step of administering a therapeutically effective amount of an antibody molecule comprising a serum albumin antibody or antigen-binding fragment thereof comprising a heavy chain variable domain having the sequence given in SEQ ID NO: 2 and a light chain variable domain having the sequence given SEQ ID NO: 4. 
Protutijelo koje veže serumski albumin ili njegov fragment naznačeno time da sadrži varijabilnu domenu teškog lanca koja ima sekvencu navedenu u SEQ ID NO: 2 i varijabilnu domenu lakog lanca koja ima sekvencu navedenu u SEQ ID NO:4.
The present invention thus refers to a method for processing of pozzolans comprising fly ash, such as Class F and/or Class C fly ash, used for preparation of mortars and concretes, characterized in, that the pozzolans is subjected to a high energetic mechanical processing by means of grinding in a grinding equipment to a fineness of the final product with a retention on a sieve 30 microns being less than 5%, whereby the pozzolan particles receive mechanical impulses when non-cenosphere in the form of coarse scoria particles are disintegrated and whereby the surface of cenosphsre grinded particles is activated. 
HR P20190526 T1 PATENTNI ZAHTJEVI Postupak za obradu pucolana u obliku letećeg pepela, kao što je leteći pepeo klase F i/ili klase C koji se koristi za pripremu mortova i betona, pri čemu su u letećem pepelu nastale kristalne ili kvazi-kristalne faze, takozvana troska, naznačen time što se pucolan podvrgava visoko energetskoj mehaničkoj obradi mljevenjem u opremi za mljevenje tako da konačni proizvod ima sljedeću raspodjelu veličine čestica:
producing an active ingredient trituration wherein the active ingredient is pramipexole or a pharmaceutically acceptable salt thereof by preblending it with a portion of water swelling polymer(s) and/or excipient(s) in a mixer, wherein pramipexole or the pharmaceutically acceptable salt thereof is milled prior to use; 
(1) pripravu triturata aktivnog sastojka pri čemu je aktivni sastojak pramipeksol ili njegova farmaceutski više pomoćnog sredstva u mjošalici, pri čemu su pramipeksol ili njegova farmaceutski prihvatljiva sol mljeveni, povoljno je mljeveni u klinastom mlinu prije uporabe;
hydrogen, substituted or unsubstituted alkyl, 
(2) supstituirani ili nesupstituirani alkil,
The method in accordance with claim 17 further comprising the step of adding a timer to control release of the ozone. 
Postupak u skladu s patentnim zahtjevom 7, naznačen time što je dodatno vremenski raspored dezinfekcije podešen na ozonskom uređaju (100) mjeračem vremena.
The extract was evaporated and the residue recovered. 
Ekstrakt je isparen i ostatak je ponovno skupljen.
The offshore aquaculture system of claim 1, wherein the controllable positioning apparatus of each cage comprises: 
Sustav odobalne akvakulture prema zahtjevu 1, pri čemu se upravljivi uređaj za pozicioniranje (140) svake rešetke (130) sastoji od:
inhibits PKCe reversibly with an IC50 of less than 1 µM. 
inhibira PKCe reverzibilno s IC50 s manje od 1 uM.
Haloperidol was prepared in hydroxyethylcellulose, 0.5% in deionized water. 
Haloperidol je bio pripremljen u hidroksietilcelulozi, 0.5% u deiomiziranoj vodi.
In one embodiment, the oligomer further includes at least one of a modified internucleoside linkage and a modified nucleobase. 
Oligomer prema zahtjevu 1, naznačen time da oligomer nadalje sadrži barem jedno od modificirane internukleotide spojnice i modificirane nukleobaze.
Method as claimed in claims 10 and 11 characterized by the further step of wholly coating the bottom of the said formwork with a layer of non woven fabric or equivalent sealing means. 
Postupak sukladno zahtjevima 10 i 11 naznačen daljnjim korakom potpunog prekrivanja okvira slojem netkanog materijala ili ekvivalentnog sredstva za zatvaranje.
According to a further aspect, the present invention provides a process for the preparation of an aqueous slurry having a solids content of more than 78 wt %, wherein a first fraction F1 of a mineral material is provided which has a percentage P5(F1) by weight of particles having a diameter of less than 5.0 um of from 75% to 85%, preferably from 80% to 85%, and a median particle diameter d50 of from 2.0 to 3.0 um, preferably from 2.3 to 2.7 um; and a second fraction F2 of a mineral material is provided which has a percentage P2(F2) by weight of particles having a diameter of less than 2.0 um of from 85% to 100%, preferably from 95% to 100%, and a median particle diameter d50 of from 0.3 to 0.65 um, preferably from 0.3 to 0.6 um; and both fractions are dispersed in water. 
Mineralni materijal u skladu s patentnim zahtjevom 9, naznačen time što je mineralni materijal suhi mineralni materijal. Postupak priprave vodenog mulja koji ima sadržaj čvrstih tvari veći od 78 %, težinski, u skladu s bilo kojim od patentnih zahtjeva 1 do 8, naznačen time što se dodaje prvu frakciju F1 mineralnog materijala, koja ima postotak Ps(F1), težinski, čestica promjera manjeg od 5,0 um od 75% do 85%, uz srednji promjer čestica dsg od 2,0 do 3,0 um, te se dodaje drugu frakciju F2 mineralnog materijala, koja ima postotak P2(F2), težinski, čestica promjera manjeg od 2,0 um od 85 % do 100 %, uz srednji promjer čestica dsg od 0,3 do 0,65 um, gdje su obje frakcije dispergirane u vodi.
wherein the preparation thereof is conducted in an atmosphere of inert gas and wherein the amount of arginine as a molar ratio to pemetrexed diacid is at least 2.5:1 (arginine:pemetrexed diacid) and said amount of arginine is sufficient to reach a pH of the composition in the range from 8.3 to 9.1. 
gdje se njegovu pripravu provodi u atmosferi od inertnog plina, a arginin je prisutan u količini dovoljnoj za postizanje pH pripravka u rasponu od 8,3 do 9,1. Pripravak u skladu s patentnim zahtjevom 1, naznačen time što je monotiolni antioksidans l-cistein.
B is a cycloalkyl, heterocycloalkyl, aromatic or heteroaromatic ring containing ring moieties Q5, Q6, Q7 and Q8, which are taken together with the carbons at positions a and a' to form ring B; 
B je cikloalkil, heterocikloalkil, aromatični ili heteroaromatični prsten koji sadrži dijelove prstena Q', Q*, Qi O, koji su uzeti zajedno sa ugljicima na pozicijama a i a' da formiraju prsten B;
A compound of formula (III): wherein R1 represents hydrogen or C1-4 alkyl group, and R2 represents hydrogen or C1-4 alkyl group. 
5 R' predstavlja vodik ili C,.4 alkil skupinu, i R" predstavlja vodik ili C,. alkil skupinu.
Optionally, a pressure control device or PCD (available commercially -- see component 56 in dashed lines in Figure 2) could be used to adjust the amount of air pressure from compressor 50 to conduit 14. 
Po želji, može se koristiti regulator tlaka (PCD) (komercijalno dostupan - vidjeti komponentu 56 prikazanu isprekidanim linijama na slici 2) za podešavanje količine zraka pod tlakom od kompresora 50 do cjevovoda 14.
the combining of step (a) is carried out at a temperature of up to 85°C; and/or 
(11) korak kombiniranja (a) je izveden na temperaturi do 85?C; i/ili
Sift together the flour and sugar. Fold in the flour-sugar mixture and mix gently. 
Pomiješati brašno i šećer, usipati u smjesu i pažljivo promiješati.
Examples of substituents include, but are not limited to, halo, hydroxyl, amino, cyano, nitro, mercapto, alkoxycarbonyl, amido, carboxy, alkanesulfonyl, alkylcarbonyl, carbamido, carbamyl, carboxyl, thioureido, thiocyanato, sulfonamido, alkyl, alkenyl, alkynyl, alkyloxy, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, in which alkyl, alkenyl, alkynyl, alkyloxy, aryl, heteroaryl cycloalkyl, and heterocycloalkyl may further substituted. The pyrimidine compounds described above include their pharmaceutically acceptable salts, hydrate and prodrug, if applicable. 
R, je alkil; pri čemu su alkil, cikloalkil, heterocikloalkil, aril, heteroaril, 1 alkoksi opcionalno supstituirani sa barem jednom skupinom odabranom od halo, hidroksil, amino, cijano, nitro, merkapto, alkoksikarbonil, amido, karboksi, alkansulfonil, alkilkarbonil, karbamido, karbamil, karboksil, tioureid, tiocijanat, sulfonamido, alkil, alkenil, alkinil, alkiloksi, aril, heteroaril, cikloalkil i heterocikloalkil, pri čemu alkil, alkenil, alkinil, alkoksi, aril, heteroaril, cikloalkil, i heterocikloalkil mogu biti daljnje supstituirani; ili njegova farmaceutski prihvatljiva sol.
Process according to claim 6, characterized in that it is an inhalable aerosol with or without propellant. 
Postupak u skladu s patentnim zahtjevom 6, naznačen time, da je aerosol za inhaliranje sa ili bez potisnog plina.
The method of claim 1, wherein the formulation is selected from the group consisting of: A) 
Kruta oralna farmaceutska formulacija prema zahtjevu 1, naznačena time što je formulacija kapsula odabrana iz skupine koja sadrži:
A representative amount in a powder or tablet may contain from 0.5 to about 90 percent of the active compound; however, an artisan would know when amounts outside of this range are necessary. 
Tipična količina praha ili tablete može sadržavati od 0.5 do oko 90 posto aktivnog sastojka; naravno, stručnjak će znati kada je neophodno odstupanje od tog raspona.
wt % calcium phosphate monobasic. 
1,4 mas. % monobazičnog kalcijevog fosfata.
for a compound of Formula I where X is O, coupling a corresponding compound having the formula II with a corresponding compound having the formula III in the presence carbonyldiimidazole or triphosgene and a base; or 
Postupak za dobivanje spoja prema zahtjevu 1, koji sadrži: (a) za spoj s formulom I gdje X je O, sparivanje odgovarajućeg spoja koji ima formulu HI RA Rb
828 being the first of the intracellular domain). 
(32) Datum podnošenja prve prijave: 02.08.2007.
A sealable container according to claim 1, wherein the base and the continuous side wall are made of a monolayer of PET. 
Posuda prema Zahtjevu 2, gdje se osnova i neprekidni bočni zid sastoje prvenstveno od recikliranog PET.
wherein the evaluation device is in communication with the temperature measuring device and is configured to determine whether there is a congestion of the multi-phase flow based on the temperature. The sensor of claim 7 wherein the evaluation device includes a data set comprising a reference measurement of the multi-phase flow, and the evaluation device is configured to evaluate the electric signal by comparing the electric signal to the data set. 
Nadzorni uređaj (100) prema jednom od patentnih zahtjeva 12 i 13, naznačen time da je elektronski uređaj za procjenu signala konverteru vibracija i/ili za uspoređivanje ulaznih signala konvertera (112) vibracija senzora (1) protoka sa skupom podataka smještenih u elektronskom uređaju za procjenu.
The coated tablet of claim 1 wherein the intra-granular fraction comprises about 50% of the total weight of the formulation, and wherein the extra-granular fraction comprises about 50% of the total weight of the formulation. 
Metoda iz zahtjeva 1. ili zahtjeva 2., pri čemu intragranularna frakcija čini 50 % ukupne težine formulacije i pri čemu ekstragranularna frakcija čini 50 % ukupne težine formulacije.
Threads 38 on bottle 20 could mate with threads in concave receiving cup 32 of receiver 30 to allow removable securement of bottle 20 to system 10. 
Navoj 38 na boci 20 povezuje se s unutarnjim navojem konkavne prihvatne čaše 32 nosača 30 kako bi se omogućilo razdvojivo pričvršćenje boce 20 u sustav 10.
removing the reaction products from the reaction chamber. The method according to claim 1, wherein the bulk material and the gas comprising carbon dioxide are conducted through the reaction chamber in opposite directions. 
Postupak prema zahtjevu 1, naznačen time, da se gomila materijala (9) i plin koji sadrži ugljični dioksid, provode kroz reakcijsku komoru (7) u suprotnim smjerovima.
where * is the attachment site to the uracil nitrogen atom, 
* je mjesto spajanja na dušikov atom na uracilu,
Authentication method according to claim 1 or 2, wherein the Manager is associated to an electronic equipment in the form of a mobile phone terminal and the text messages exchanged between the Manager electronic equipment and the Intermediary electronic equipment are phone text messages, in particular SMS and/or MMS. 
Postupak autentifikacije sukladno Zahtjevu 1 ili 2, pri čemu je Upravitelj povezan s elektroničkom opremom u obliku terminala mobilnog telefona, a tekstualne poruke razmijenjene između elektroničke opreme Upravitelja 1 elektroničke opreme Posrednika su telefonske tekstualne poruke, osobito SMS (kratke tekstualne poruke) i/ili MMS (multimedijalne poruke).
Process for the production of gel-based composite materials 
POSTUPAK PROIZVODNJE KOMPOZITNIH MATERIJALA NA BAZI GELA
Figure 2 shows the Raman spectrum obtained for 3-phenylsulfonyl-8-piperazin-1-yl-quinoline (Form III). 
Slika 2 pokazuje Ramanski spektar dobiven za 3-fenilsulfonil-8-piperazin-1-ilkinolin (Oblik III).
transferring, simultaneously from the K levels of the exit elevator to the K levels of the exit transfer device, said group of N loads; and transferring of said group of N loads, via the exit sequencer, from the K levels of the exit transfer device to the at least one exit interface conveyor, under a constraint of order of departure the N loads on said at least one exit interface conveyor. 
– transport (72), istodobno na K razina, navedene skupine od N komada robe od ulaznog transportnog uređaja do ulaznog dizala; i – prilikom ponavljanja navedenog ciklusa dizanja i spuštanja, transport (72) navedene skupine od N komada robe, od ulaznog dizala do najmanje jednog višerazinskog skladišnog kompleksa, uz pridržavanje navedenog ograničavanja spremanja N komada robe.
connection or common connection aperture (91) closed and right and left exhaust tract aperture fully closed; 
priključak ili zajednički otvor za spajanje (91) je zatvoren i desni i lijevi otvor ispušnog kraka su potpuno zatvoreni.
Embodiment 74: A pharmaceutical composition comprising an antibody according to any of embodiments 1 to 53 or an immunoconjugate according to any of embodiments 70 to 71 or a bispecific or multispecific molecule according to any of embodiments 72 to 73 and a pharmaceutically acceptable carrier. 
16. Farmaceutski pripravak koji sadrži antitijelo prema bilo kojem zahtjevu od 1 do 8, imunokonjugat prema zahtjevu 13 ili bispecifičnu ili multispecifičnu molekulu prema zahtjevu 14 ili 15 te farmaceutski prihvatljiv nosač.
Compounds according to claims 1 or 2, wherein R1 represents CF3. 
Spojevi prema zahtjevima 1 do 2, naznačeni time, da se upotrebljavaju kao farmaceutska sredstva.
A ship as claimed in any one of the preceding claims 5 to 12, characterized in that it comprises a backwash system (22, 106') for cleaning the semipermeable membrane (7, 7a, 7', 7a') of the membrane filter (4, 4a, 4', 4a') of impurity particles, the backwash system being arranged to feed a fluid free of impurities in a flow direction of the semipermeable membrane (7, 7a, 7', 7a') of the membrane filter, which is opposite to the flow direction of the purified effluent. 
Brod u skladu s bilo kojim od prethodnih patentnih zahtjeva 5 do 12, naznačen time što sadrži sustav za povratno ispiranje (22, 106), namijenjen čišćenju polupropusne membrane (7, 7a, 7, 7a') membranskog filtra (4, 4a, 4, HR P20180346 T1 4a') od čestica nečistoća, gdje sustav za povratno ispiranje služi za dodavanje fluida koji ne sadrži nečistoće u smjeru toka polupropusne membrane (7, 7a, 7, 7a') membranskog filtra, što je suprotno smjeru toka pročišćenog ispusta.
The combination of any one of claims 1-10 or kit of any one of claims 11-14 wherein the ancillary therapeutic component comprises a T-cell activating agent selected from agonists or antibodies for: ICOS, GITR, MHC, CD80, CD86, Galectin 9 and LAG-3. 
Kombinacija prema bilo kojem od patentnih zahtjeva 1-10 ili komplet prema bilo kojem od patentnih zahtjeva 1114 naznačena time što pomoćna terapijska komponenta sadrži sredstvo za aktiviranje T-stanica koje je odabrano od agonista ili protutijela za: ICOS, GITR, MHC, CD$0, CD86, Galektin 9 i LAG-3.
The pulp remaining from the fruits and vegetables remain within the bore of the sieving means and the resultant juice may be decanted from the blender canister. 
Ostatak od voća i povrća ostaje unutar zapremine dijelova za prosijavanje i dobiveni sok se može izliti iz spremnika mješalice.
Wind system (1) according to claim 1, characterised in that said frictioning system is equipped with at least one pulley constrained to a linear guide and at least one spring constrained next to an end to said pulley and next to another end to a trolley (11). 
Vjetreni sustav (1) prema zahtjevu 1, naznačen time da spomenuti sustav za pokretanje i stabiliziranje uključuje najmanje jedan ometač zračne struje (spojler).
Item-6) Device according to item 5, wherein the reservoir axis is approximately perpendicular to the bore axis. 
Točka-6) = Uređaj prema točki 5, pri čemu je os spremnika otprilike okomita na os cilindrične šupljine.
As can be seen in FIG. 3, bottle 20 can have an opening 26 in end 22 through which the water and inoculant can be inserted into bottle 20 and mixed (by shaking or other methods), or a pre-mix of water/inoculant could be inserted into bottle 20 . 
Kao što se vidi na slici 3, boca 20 može imati otvor 26 na kraju 22 kroz koji se voda i inokulant mogu HR P20060161 T3 unijeti u bocu 20 i miješati (trešnjom ili drugim postupcima), ili se neka prethodna mješavina vode i inokulanta može unijeti u bocu 20.
is a halogen atom, an alkyl group having a carbon number of 1 to 6 optionally having substituent(s) or an alkoxy group having a carbon number of 1 to 6 optionally having substituent(s); 
R* je atom halogena ili alkilna skupina koja ima broj ugljika od 1 do 6 opcijski sa supstituentima ili je alkoksi-skupina koja ima broj ugljika od 1 do 6 opcijski sa supstituentima;
is hydrogen, unsubstituted or substituted C1-C20 alkyl, or unsubstituted or substituted aryl; and 
(1) Rs je vodik, nesupstituirani ili supstituirani C,-C2o-alkil, ili nesupstituirani ili supstituirani aril;